Skip to main content
Premium Trial:

Request an Annual Quote

BC Platforms, African Institute of Everyone Genome Form Genome Data Management Alliance

NEW YORK — BC Platforms said on Monday that it has partnered with the African Institute of Everyone Genome to collect genomic data on millions of people throughout the continent to improve drug development and clinical research.

Through the alliance, AIEG will use BC Platforms' Discovery and Research Platform, a cloud-based data management and analytics system, to collect genomic data from over 10 million consenting individuals in all 54 African countries over the next 10 to 15 years. AIEG, a company based in South Africa, said it aims to build the largest integrated clinical and genomics database and biobank in Africa.

The data, BC Platforms said, is expected to support the identification and validation of novel targets, as well as provide early insights into adverse events, for drugs specifically designed for patients in sub-Saharan Africa.

An initial pilot cohort is expected to begin participating in the project next month.

"Our goal is for African DNA to be studied on its own and be part of clinical trials for new and novel therapies treating a truly global population," AIEG CEO Joe Mojapelo said in a statement. "Through the [real-world data] that will be produced by future studies in collaboration with [BC Platforms], leveraging their integrated cloud-based platform alongside our region-leading database, we are keen to contribute to a new world of research equity."

Earlier this year, Zurich-based BC Platforms began a data-management alliance with CureDuchenne, a nonprofit focused on Duchenne muscular dystrophy research.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.